Company intelligence / Profile preview

Xi'an Libang Pharmaceutical

Xi'an, Shaanxi, Chinaen.lbdrigging.com ↗

Ownership: Private
Development stage: Commercial

Overview

Xi'an Libang Pharmaceutical is one of China's largest generic suppliers of propofol (anesthesia), with multiple approved injectable anesthetics and APIs, and a track record of strong commercial sales and GMP compliance in both China and international markets. Several generic products are FDA-approved, and new products like dipropofol are in early clinical trials.[1][2][3][8]

Therapeutic areas: OtherPulmonologyNeurologyWomen's Health
Modalities: Small moleculeBiologic
Industry: Biotech

Beyond the preview

Go deeper on Xi'an Libang Pharmaceutical.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Xi'an Libang Pharmaceutical.

Explore the full profile